Correlation Between Maxigen Biotech and Orient Pharma

Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maxigen Biotech and Orient Pharma Co, you can compare the effects of market volatilities on Maxigen Biotech and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and Orient Pharma.

Diversification Opportunities for Maxigen Biotech and Orient Pharma

0.45

Correlation Coefficient

Maxigen Biotech  Orient Pharma

Very weak diversification

The 3 months correlation between Maxigen and Orient is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and Orient Pharma go up and down completely randomly.

Pair Corralation between Maxigen Biotech and Orient Pharma

Assuming the 90 days trading horizon Maxigen Biotech is expected to generate 0.54 times more return on investment than Orient Pharma. However, Maxigen Biotech is 1.87 times less risky than Orient Pharma. It trades about 0.2 of its potential returns per unit of risk. Orient Pharma Co is currently generating about -0.02 per unit of risk. If you would invest  4,455  in Maxigen Biotech on September 25, 2024 and sell it today you would earn a total of  265.00  from holding Maxigen Biotech or generate 5.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Maxigen Biotech  vs.  Orient Pharma Co

Maxigen Biotech

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Maxigen Biotech and Orient Pharma

The main advantage of trading using opposite Maxigen Biotech and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.

The idea behind Maxigen Biotech and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.